Pharma Company Agrees to Pay $23M to Settle Claims It Secretly Controlled Pharmacies

Valeant Pharmaceuticals is settling a class action lawsuit filed by investors. Why: The investors alleged Valeant securities were artificially inflated due to the concealment of Valeant’s “unsustainable and deceptive” price gouging practices wherein Valeant acquired pre-existing drugs, some of them life-saving medicines, and then dramatically raised prices to boost short-term profitability.

Read the source article at Top Class Actions
2021-08-09 20:47:50